Covaxin to Be Evaluated as COVID-19 Vaccine Candidate in US, Says Bharat Biotech : vimarsana.com

"Ocugen, Inc (NASDAQ: OCGN) announced that the US Food and Drug Administration (FDA) has lifted its clinical hold on the Company's Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as Covaxin outside the United States. Covaxin to Be Evaluated as COVID-19 Vaccine Candidate in US, Says Bharat Biotech.

Related Keywords

United States , India , Hyderabad , Andhra Pradesh , Canada , Bharat , , Company Investigational New Drug , Ministry Of Health , Drug Administration , Ocugen Inc , Hyderabad Based Bharat Biotech , Investigational New Drug , Bharat Biotech , More Than , Family Welfare , Bbv152 , Covaxin , Covaxin Vaccine , Covid 19 Vaccine , Us , Us Food And Drug Administration ,